Fig. 10

(a) Separation of all infected samples from mock samples using the top three gene signatures, OAS1, ISG15, and IFI44L, identified in Sect. 3.3 on the held-out test set. (b) Differentiation of mock-infected samples from EBOV-infected samples using gene signatures CASP5, USP18, and DDX60, identified in RNA-Seq but not included in NanoString, as detailed in Sect. 3.4, on the held-out test set